Drug information for ZENAPAX
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
VIAL
25MG/VIAL
Prescription
DACLIZUMAB
daclizumab
HOFFMAN-LA ROCHE
103749
2006-12-04 Letter
2006-11-28 Label
2004-03-30 Letter
2004-03-30 Label
2004-03-30 Review
2004-03-30 Letter
2004-03-30 Label
Drug Adverse Effects information for ZENAPAX
Role code
Indications
Reaction
# Reports
PS
ANTIVIRAL PROPHYLAXIS
ABDOMINAL INFECTION
2
PS
ANTIVIRAL PROPHYLAXIS
GRAFT DYSFUNCTION
2
PS
ANTIVIRAL PROPHYLAXIS
GRAFT INFECTION
2
PS
ANTIVIRAL PROPHYLAXIS
INTRA-ABDOMINAL HAEMORRHAGE
2
PS
ANTIVIRAL PROPHYLAXIS
PNEUMONIA CYTOMEGALOVIRAL
2
PS
ANTIVIRAL PROPHYLAXIS
TRANSPLANT REJECTION
2
PS
GRAFT INFECTION
ABDOMINAL INFECTION
1
PS
GRAFT INFECTION
GRAFT DYSFUNCTION
1
PS
GRAFT INFECTION
GRAFT INFECTION
1
PS
GRAFT INFECTION
INTRA-ABDOMINAL HAEMORRHAGE
1
PS
GRAFT INFECTION
PNEUMONIA CYTOMEGALOVIRAL
1
PS
GRAFT INFECTION
TRANSPLANT REJECTION
1
PS
PNEUMONIA CYTOMEGALOVIRAL
ABDOMINAL INFECTION
1
PS
PNEUMONIA CYTOMEGALOVIRAL
GRAFT DYSFUNCTION
1
PS
PNEUMONIA CYTOMEGALOVIRAL
GRAFT INFECTION
1
PS
PNEUMONIA CYTOMEGALOVIRAL
INTRA-ABDOMINAL HAEMORRHAGE
1
PS
PNEUMONIA CYTOMEGALOVIRAL
PNEUMONIA CYTOMEGALOVIRAL
1
PS
PNEUMONIA CYTOMEGALOVIRAL
TRANSPLANT REJECTION
1
PS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
BACTERIAL INFECTION
2
PS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
CYTOMEGALOVIRUS INFECTION
2
PS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
DIABETES MELLITUS
2
PS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
URINARY TRACT INFECTION
2
PS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
WOUND INFECTION
2
PS
RENAL TRANSPLANT
BACTERIAL INFECTION
4
PS
RENAL TRANSPLANT
CYTOMEGALOVIRUS INFECTION
4
PS
RENAL TRANSPLANT
DIABETES MELLITUS
4
PS
RENAL TRANSPLANT
URINARY TRACT INFECTION
4
PS
RENAL TRANSPLANT
WOUND INFECTION
4
PS
SMALL INTESTINE TRANSPLANT
ABDOMINAL INFECTION
3
PS
SMALL INTESTINE TRANSPLANT
GRAFT DYSFUNCTION
3
PS
SMALL INTESTINE TRANSPLANT
GRAFT INFECTION
3
PS
SMALL INTESTINE TRANSPLANT
INTRA-ABDOMINAL HAEMORRHAGE
3
PS
SMALL INTESTINE TRANSPLANT
PNEUMONIA CYTOMEGALOVIRAL
3
PS
SMALL INTESTINE TRANSPLANT
TRANSPLANT REJECTION
3
SS
INTESTINAL TRANSPLANT
FUNGAL INFECTION
3
SS
LIVER TRANSPLANT
LUNG INFECTION
3
SS
LIVER TRANSPLANT
MULTI-ORGAN FAILURE
3
SS
LIVER TRANSPLANT
SEPSIS
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
ALOPECIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
GRAFT DYSFUNCTION
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
PNEUMONIA
1
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
ACUTE PULMONARY OEDEMA
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
BK VIRUS INFECTION
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
CYTOMEGALOVIRUS INFECTION
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
LYMPHOPROLIFERATIVE DISORDER
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
NEPHROTIC SYNDROME
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
PULMONARY TUBERCULOSIS
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
SEPSIS
8
SS
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
SEPTIC SHOCK
8
C
IMMUNOSUPPRESSANT DRUG THERAPY
DEHYDRATION
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
DIARRHOEA
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
DRUG INEFFECTIVE
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
ESCHERICHIA SEPSIS
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
HYPERCHLORAEMIA
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
HYPOMAGNESAEMIA
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
INTESTINE TRANSPLANT REJECTION
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
KLEBSIELLA SEPSIS
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
METABOLIC ACIDOSIS
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
RENAL IMPAIRMENT
3
C
IMMUNOSUPPRESSANT DRUG THERAPY
TRANSPLANT REJECTION
3
C
SMALL INTESTINE TRANSPLANT
DEHYDRATION
3
C
SMALL INTESTINE TRANSPLANT
DIARRHOEA
3
C
SMALL INTESTINE TRANSPLANT
DRUG INEFFECTIVE
3
C
SMALL INTESTINE TRANSPLANT
ESCHERICHIA SEPSIS
3
C
SMALL INTESTINE TRANSPLANT
HYPERCHLORAEMIA
3
C
SMALL INTESTINE TRANSPLANT
HYPOMAGNESAEMIA
3
C
SMALL INTESTINE TRANSPLANT
INTESTINE TRANSPLANT REJECTION
3
C
SMALL INTESTINE TRANSPLANT
KLEBSIELLA SEPSIS
3
C
SMALL INTESTINE TRANSPLANT
METABOLIC ACIDOSIS
3
C
SMALL INTESTINE TRANSPLANT
RENAL IMPAIRMENT
3
C
SMALL INTESTINE TRANSPLANT
TRANSPLANT REJECTION
3
Ads by Google